Intravenous Thrombolysis vs. Mechanical Thrombectomy: Key Differences
Intravenous thrombolysis (IV tPA) and mechanical thrombectomy are fundamentally different reperfusion strategies for acute ischemic stroke—IV tPA is a pharmacological clot-dissolving drug administered through a peripheral vein, while thrombectomy is a catheter-based procedure that physically removes the clot from the blocked artery.
Mechanism of Action
IV Thrombolysis:
- Delivers recombinant tissue plasminogen activator (r-tPA/alteplase) systemically through a peripheral IV line 1
- Works by enzymatically dissolving the blood clot throughout the vascular system
- Non-invasive administration requiring only IV access
- Dose: 0.9 mg/kg (maximum 90 mg), with 10% given as bolus over 1 minute, remainder over 60 minutes 2
Mechanical Thrombectomy:
- Requires catheter-based endovascular access via femoral artery puncture 3, 4
- Physically retrieves or aspirates the clot using specialized devices (stent retrievers like Solitaire FR/Trevo, or aspiration systems like Penumbra) 3, 4
- Invasive procedure requiring interventional neuroradiology team, angiography suite, and often general anesthesia 1
- Directly targets the occlusion site under fluoroscopic guidance
Time Windows
IV Thrombolysis:
- Strongest recommendation within 3 hours of symptom onset (Grade 1A) 1
- Can be used up to 4.5 hours (Grade 2C recommendation) 1, 2
- Contraindicated beyond 4.5 hours in standard protocols (Grade 1B) 1
- In imaging-selected patients (DWI-FLAIR mismatch), may extend to wake-up strokes 2
Mechanical Thrombectomy:
- Primary window: up to 6 hours for patients meeting specific criteria 4, 5
- Extended window: 6-24 hours possible with advanced imaging showing salvageable tissue (perfusion/core mismatch) 2, 4
- Significantly longer treatment window than IV tPA alone
Patient Selection Criteria
IV Thrombolysis:
- Broader eligibility—any acute ischemic stroke within time window
- Does not require vascular imaging to identify occlusion location
- Multiple contraindications (recent surgery, bleeding risk, severe hypertension >185/110 mmHg) 2
- Can treat both large and small vessel occlusions
Mechanical Thrombectomy:
- Requires documented large vessel occlusion (internal carotid artery or M1 segment of middle cerebral artery) 4, 5
- Specific criteria: prestroke mRS 0-1, NIHSS ≥6, ASPECTS ≥6, age ≥18 years 4
- Requires vascular imaging (CTA/MRA) to confirm target occlusion 6, 7
- Not effective for small vessel or lacunar strokes
Recanalization Efficacy
IV Thrombolysis:
- Lower recanalization rates, particularly for proximal occlusions 8:
- Distal MCA: 44% complete recanalization
- Proximal MCA: 30% complete recanalization
- Terminal ICA: only 6% complete recanalization
- Basilar artery: 30% complete recanalization
- More effective for distal, smaller clots
Mechanical Thrombectomy:
- Superior recanalization rates for large vessel occlusions 4, 5
- Target: modified TICI 2b/3 reperfusion (≥50% territory reperfused) 3
- Particularly effective for proximal large clots with high burden 8
Logistics and Resource Requirements
IV Thrombolysis:
- Can be administered at any hospital with CT scanner and stroke protocol 1
- Requires only emergency physician or neurologist
- Door-to-needle time target: <60 minutes (ideally <45 minutes) 7
- Minimal specialized infrastructure needed
Mechanical Thrombectomy:
- Requires comprehensive stroke center with 24/7 interventional neuroradiology 3
- Needs angiography suite, specialized devices, and trained interventionalists
- Longer door-to-reperfusion times due to procedural setup 1, 8
- Many patients require transfer to thrombectomy-capable centers
Combined Therapy (Bridging)
The current evidence strongly supports combined IV tPA plus thrombectomy over thrombectomy alone when patients present to thrombectomy-capable centers within the IV tPA time window 4, 9. However, this benefit is time-dependent:
- At 1 hour from onset: 9% absolute benefit for combined therapy 9
- At 2 hours: 5% absolute benefit 9
- At 3 hours: 1% benefit (not statistically significant) 9
- Benefit becomes non-significant after 2 hours 20 minutes from symptom onset 9
Critical principle: Do NOT delay thrombectomy to observe response to IV tPA—proceed directly to angiography suite (Class III Harm recommendation) 4. Every hour delay to reperfusion reduces favorable outcomes 4.
Safety Profile
IV Thrombolysis:
- Symptomatic intracranial hemorrhage (sICH): approximately 6-7% 1, 10
- Systemic bleeding complications possible
- Lower procedural risk (no arterial access complications)
Mechanical Thrombectomy:
- Similar sICH rates when used alone 11
- Additional risks: arterial dissection, perforation, groin hematoma, distal embolization 3
- When combined with IV tPA: any ICH occurs more frequently (50.5% vs 33.7%) but symptomatic ICH rates similar 11
Clinical Outcomes
For large vessel occlusions, mechanical thrombectomy demonstrates superior functional outcomes compared to IV tPA alone 4, 5. The pooled analysis from major trials (MR CLEAN, ESCAPE, EXTEND-IA, SWIFT PRIME, REVASCAT) shows:
- Common odds ratio for better disability outcomes: 2.49 with thrombectomy 4
- Number needed to treat: approximately 3-4 patients for one additional good outcome 5
However, IV tPA remains essential because:
- Many strokes involve non-LVO that thrombectomy cannot address
- It can achieve early recanalization before thrombectomy 12
- It improves thrombectomy success rates when used as bridging therapy 13, 12
Common Pitfalls
- Do not withhold IV tPA while arranging thrombectomy—administer immediately if eligible, then proceed to angiography 4
- Do not use IV tPA beyond 4.5 hours without advanced imaging selection criteria 1
- Do not attempt thrombectomy for non-LVO strokes—requires documented proximal occlusion 4
- Do not delay thrombectomy for non-essential imaging in eligible patients 4